SNM hails passage of new radiopharmaceutical-reimbursement law

07/31/2008 | Diagnostic Imaging

The U.S. Congress earned praise from the Society of Nuclear Medicine and industry representatives for passing a bill that seeks to provide adequate reimbursement for radiopharmaceuticals, including Bexxar and Zevalin. "Thousands of patients will benefit and live longer if the government and private payers adequately reimburse highly effective radioimmunotherapies," SNM President Robert Atcher said.

View Full Article in:

Diagnostic Imaging

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ